Auf dieser Seite
LONA LeonaBio, Inc. - Common Stock
NASDAQ · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 14, 2026
$4,82
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,2152-Wochen-Tief
$14,2152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$45M
P/E
-0.2
EPS
$-24.70
Ihre Abzeichen
52W-Spanne
$2–$14
Analystenbewertung
BUY
Kursziel
$17
P/E
-0.2
ROE
-353.4%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
LONA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.82
Marktkapitalisierung (MRQ)
$45M
P/E
-0.2
EPS
$-24.70
ROE
-353.4%
52W-Spanne
$2–$14
LONA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 18. September 2025 | 1-for-10 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-24.702021-12-31 → 2025-12-31
Freier Cashflow·2020-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | LONA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -0.2 | · | · | · | |
| K/B (MRQ) | 1.4 | · | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -1.0 | · | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.6 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | LONA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -139.9%5-Jahres-Durchschnitt ≈-67.0% | ≈-67.0% | · | · | |
| ROE | -353.4%5-Jahres-Durchschnitt ≈-136.1% | ≈-136.1% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | LONA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 7.05-Jahres-Durchschnitt ≈9.8 | ≈9.8 | · | · | |
| Quick Ratio | 1.95-Jahres-Durchschnitt ≈9.5 | ≈9.5 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-15.6%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 14, 2026 | $-0.80 | $-1.29 | 38.0% |
| 31. März 2026 | Mai 7, 2026 | $-1.73 | $-2.55 | 32.2% |
| 31. Dezember 2025 | $-3.46 | $-1.30 | -165.7% | |
| 30. September 2025 | $-1.68 | $-1.24 | -35.0% | |
| 30. Juni 2025 | $-1.80 | $-1.84 | 2.0% | |
| 31. März 2025 | $-2.30 | $-2.45 | 6.0% | |
| 31. Dezember 2024 | $-3.90 | $-4.49 | 13.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $71M | $94M | $61M | $43M | $13M | $4M | |
| SG&A Expense | $17M | $26M | $33M | $33M | $21M | $7M | $2M | |
| Operating Expenses | $102M | $101M | $125M | $104M | $64M | $20M | $5M | |
| Operating Income | $-102M | $-101M | $-125M | $-104M | $-64M | $-20M | $-5M | |
| Interest Expense | · | · | · | · | $3.0K | $367.0K | $346.0K | |
| Other Non-op | $1M | $4M | $8M | $3M | $334.0K | $-1M | $-466.0K | |
| Pretax Income | · | · | · | · | · | $-20M | $-5M | |
| Income Tax | $0 | · | · | · | · | · | · | |
| Net Income | $-106M | $-97M | $-118M | $-96M | $-55M | $-20M | $-5M | |
| EPS (Basic) | $-24.70 | $-25.19 | $-3.09 | $-2.53 | $-1.49 | · | · | |
| EPS (Diluted) | $-24.70 | $-25.19 | $-3.09 | $-2.53 | $-1.49 | · | · | |
| Shares (Basic) | 4,275,762 | 3,848,044 | 38,020,182 | 37,733,240 | 36,921,172 | · | · | |
| Shares (Diluted) | 4,275,762 | 3,848,044 | 38,020,182 | 37,733,240 | 36,921,172 | · | · | |
| EBITDA | $-102M | $-101M | $-125M | $-104M | $-64M | $-20M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $69M | $48M | $91M | $96M | $111M | $61M | $2M | |
| Short-term Investments | $19M | $3M | $57M | $104M | $143M | $124M | · | |
| Prepaid Expense | $1M | $4M | $6M | $6M | $5M | $6M | $97.0K | |
| Current Assets | $89M | $55M | $155M | $208M | $261M | $192M | $2M | |
| PP&E (Net) | $1M | $2M | $3M | $4M | $4M | $3M | · | |
| PP&E (Gross) | $6M | $6M | $6M | $5M | $4M | $3M | $69.0K | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $523.0K | $71.0K | $69.0K | |
| Other Non-current Assets | $55.0K | $55.0K | $448.0K | $55.0K | $56.0K | $132.0K | · | |
| Total Assets | $92M | $59M | $160M | $258M | $332M | $280M | $2M | |
| Accounts Payable | $5M | $319.0K | $129.0K | $3M | $567.0K | $1M | $421.0K | |
| Accrued Liabilities | $5M | $12M | $18M | $9M | $8M | $3M | $852.0K | |
| Current Liabilities | $48M | $13M | $29M | $21M | $9M | $4M | $1M | |
| Capital Leases | $338.0K | $803.0K | $1M | $2M | $2M | $876.0K | · | |
| Other Non-current Liabilities | $1M | · | · | · | · | · | · | |
| Total Liabilities | $64M | $14M | $30M | $23M | $11M | $5M | $5M | |
| Common Stock | $1.0K | $0 | $4.0K | $4.0K | $4.0K | $3.0K | · | |
| Retained Earnings | $-512M | $-406M | $-309M | $-192M | $-96M | $-41M | $-21M | |
| AOCI | $-4.0K | $1.0K | $-349.0K | $-2M | $-388.0K | $33.0K | · | |
| Stockholders' Equity | $28M | $45M | $130M | $235M | $321M | $274M | $-20M | |
| Liabilities + Equity | $92M | $59M | $160M | $258M | $332M | $280M | $2M | |
| Shares Outstanding | 9,335,913 | 3,904,049 | 38,172,603 | 37,877,387 | 37,379,077 | 32,485,784 | 3,641,449 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $11M | $11M | $11M | $5M | $633.0K | $253.0K | |
| Operating Cash Flow | $-46M | $-97M | $-101M | $-72M | $-43M | $-24M | $-4M | |
| CapEx | · | $33.0K | $304.0K | $1M | $2M | $2M | · | |
| Investing Cash Flow | $-16M | $55M | $95M | $58M | $-4M | $-210M | $2M | |
| Stock Issued | $90M | · | · | · | · | · | · | |
| Net Stock Activity | $90M | · | · | · | · | · | · | |
| Financing Cash Flow | $82M | $194.0K | $493.0K | $654.0K | $97M | $293M | $946.0K | |
| Net Change in Cash | $21M | $-42M | $-5M | $-14M | $50M | $59M | $-1M | |
| Free Cash Flow | · | $-97M | $-101M | $-74M | $-45M | $-26M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -139.9% | -88.5% | -56.2% | -32.4% | -17.9% | -14.2% | · | |
| ROE | -353.4% | -189.3% | -82.6% | -38.5% | -16.7% | -7.5% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 4.2 | 5.4 | 9.7 | 28.1 | 43.7 | · | |
| Quick Ratio | 1.9 | 3.9 | 5.1 | 9.3 | 27.3 | 41.9 | · | |
| Interest Coverage | · | · | · | · | -21340.7 | -54.5 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.98 | $1.15 | $3.41 | $6.21 | $8.59 | $8.44 | · | |
| Cash Flow / Share | $-10.69 | $-2.53 | $-2.65 | $-1.92 | · | · | · | |
| Cash / Share | $7.42 | $1.24 | $2.37 | $2.53 | $2.96 | $1.87 | · | |
| EPS (TTM) | $-24.70 | $-25.19 | $-3.09 | $-2.53 | $-1.49 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-106M | $-97M | $-118M | $-96M | $-55M | $-20M | · | |
| Market Cap | $71M | $229M | · | · | · | · | · | |
| P/E | -0.3 | -0.2 | · | · | · | · | · | |
| P/B | 2.5 | 5.1 | · | · | · | · | · | |
| P / Tangible Book | 2.5 | 5.1 | · | · | · | · | · | |
| P / Cash Flow | -1.5 | -2.4 | · | · | · | · | · | |
| P / FCF | · | -2.4 | · | · | · | · | · | |
| Earnings Yield | -326.3% | -429.1% | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $11M | $7M | $3M | $4M | $4M | $9M | $18M | $22M | $21M | $24M | $27M | $22M | $21M | $15M | $17M | |
| SG&A Expense | $7M | $7M | $4M | $4M | $4M | $5M | $6M | $8M | $6M | $6M | $7M | $8M | $10M | $8M | $8M | $7M | |
| Operating Expenses | $19M | $17M | $79M | $7M | $7M | $10M | $16M | $30M | $28M | $28M | $29M | $35M | $32M | $30M | $33M | $24M | |
| Operating Income | $-19M | $-17M | $-79M | $-7M | $-7M | $-10M | $-16M | $-30M | $-28M | $-28M | $-29M | $-35M | $-32M | $-30M | $-33M | $-24M | |
| Other Non-op | $446.0K | $586.0K | $255.0K | $263.0K | $325.0K | $393.0K | $563.0K | $880.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $985.0K | |
| Net Income | $-19M | $-33M | $-83M | $-7M | $-7M | $-9M | $-15M | $-29M | $-27M | $-26M | $-27M | $-33M | $-30M | $-28M | $-30M | $-20M | |
| EPS (Basic) | $-0.80 | $-1.73 | $-22.61 | $-1.68 | $-1.78 | $-2.34 | $-16.34 | $-7.46 | $-0.70 | $-0.69 | $-0.71 | $-0.87 | $-0.78 | $-0.73 | $-0.79 | $-0.53 | |
| EPS (Diluted) | $-0.80 | $-1.73 | $-22.61 | $-1.68 | $-1.78 | $-2.34 | $-16.34 | $-7.46 | $-0.70 | $-0.69 | $-0.71 | $-0.87 | $-0.78 | $-0.73 | $-0.79 | $-0.53 | |
| Shares (Basic) | 23,726,211 | 19,027,087 | · | 3,943,887 | 3,909,297 | 3,904,244 | · | 3,851,758 | 38,379,733 | 38,321,573 | · | 38,054,583 | 37,999,578 | 37,923,402 | · | 37,817,724 | |
| Shares (Diluted) | 23,726,211 | 19,027,087 | · | 3,943,887 | 3,909,297 | 3,904,244 | · | 3,851,758 | 38,379,733 | 38,321,573 | · | 38,054,583 | 37,999,578 | 37,923,402 | · | 37,817,724 | |
| EBITDA | $-19M | $-17M | · | $-7M | $-7M | $-10M | · | $-30M | · | $-28M | · | $-35M | $-32M | $-30M | · | $-24M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $33M | $69M | $21M | $20M | $26M | $48M | $69M | $74M | $78M | $91M | $110M | $114M | $105M | $96M | $87M | |
| Short-term Investments | $19M | $35M | $19M | $4M | $10M | $10M | $3M | · | $18M | $44M | $57M | $63M | $72M | $81M | $104M | $134M | |
| Prepaid Expense | $4M | $2M | $1M | $2M | $2M | $3M | $4M | $3M | $5M | $5M | $6M | $6M | $6M | $7M | $6M | $6M | |
| Current Assets | $55M | $69M | $89M | $27M | $32M | $40M | $55M | $82M | $107M | $129M | $155M | $179M | $192M | $193M | $208M | $229M | |
| PP&E (Net) | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Accum. Depreciation | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-current Assets | $55.0K | $55.0K | $55.0K | $55.0K | $62.0K | $85.0K | $55.0K | $55.0K | $55.0K | $55.0K | $448.0K | $827.0K | $61.0K | $72.0K | $55.0K | $55.0K | |
| Total Assets | $57M | $72M | $92M | $30M | $36M | $44M | $59M | $86M | $111M | $133M | $160M | $185M | $208M | $233M | $258M | $274M | |
| Accounts Payable | $2M | $2M | $5M | $266.0K | $171.0K | $867.0K | $319.0K | $388.0K | $475.0K | $681.0K | $129.0K | $2M | $612.0K | $892.0K | $3M | $751.0K | |
| Accrued Liabilities | $5M | $4M | $5M | $2M | $2M | $4M | $12M | $17M | $16M | $15M | $18M | $17M | $11M | $9M | $9M | $9M | |
| Current Liabilities | $8M | $7M | $48M | $3M | $3M | $5M | $13M | $28M | $27M | $26M | $29M | $29M | $22M | $20M | $21M | $10M | |
| Capital Leases | $86.0K | $213.0K | $338.0K | $460.0K | $578.0K | $691.0K | $803.0K | $912.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Other Non-current Liabilities | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $23M | $22M | $64M | $3M | $4M | $6M | $14M | $29M | $28M | $27M | $30M | $30M | $23M | $22M | $23M | $12M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $4.0K | $4.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-564M | $-545M | $-512M | $-429M | $-422M | $-415M | $-406M | $-391M | $-362M | $-336M | $-309M | $-282M | $-249M | $-219M | $-192M | $-161M | |
| AOCI | $-9.0K | $-13.0K | $-4.0K | $-2.0K | $-3.0K | $-4.0K | $1.0K | $3.0K | $-38.0K | $-137.0K | $-349.0K | $-678.0K | $-939.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $34M | $49M | $28M | $27M | $32M | $37M | $45M | $58M | $83M | $107M | $130M | $155M | $185M | $211M | $235M | $262M | |
| Liabilities + Equity | $57M | $72M | $92M | $30M | $36M | $44M | $59M | $86M | $111M | $133M | $160M | $185M | $208M | $233M | $258M | $274M | |
| Shares Outstanding | 9,421,663 | 9,393,514 | 9,335,913 | 3,943,887 | 39,439,326 | 39,042,445 | 3,904,049 | 38,669,073 | 38,439,375 | 38,326,652 | 38,172,603 | 38,054,583 | 38,054,583 | 37,950,600 | 37,877,387 | 37,817,724 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $662.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-17M | $-21M | $-19M | $-5M | $-7M | $-15M | $-26M | $-23M | $-22M | $-26M | $-26M | $-24M | $-24M | $-26M | $-16M | $-22M | |
| CapEx | · | · | · | · | · | · | $0 | $0 | $28.0K | $5.0K | $0 | $30.0K | $33.0K | $241.0K | $1.0K | $244.0K | |
| Investing Cash Flow | $16M | $-16M | $-15M | $6M | $441.0K | $-7M | $-3M | $18M | $27M | $13M | $6M | $21M | $32M | $36M | $25M | $14M | |
| Financing Cash Flow | · | · | $82M | $0 | · | · | $34.0K | $12.0K | · | · | $152.0K | $0 | $242.0K | $99.0K | $147.0K | $0 | |
| Net Change in Cash | $-510.0K | $-36M | $48M | $986.0K | $-7M | $-22M | $-29M | $-5M | $4M | $-13M | $-20M | $-3M | $8M | $9M | $9M | $-8M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-26M | · | · | · | $-26M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -41.1% | -57.2% | · | -11.4% | -9.5% | -10.3% | · | -21.2% | · | -14.4% | · | -14.4% | -11.8% | -9.2% | · | -6.5% | |
| ROE | -58.0% | -76.1% | · | -15.7% | -12.1% | -12.7% | · | -27.1% | · | -16.6% | · | -15.8% | -12.7% | -9.7% | · | -6.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 10.4 | · | 9.7 | 10.8 | 7.3 | · | 3.0 | · | 5.0 | · | 6.2 | 8.9 | 9.6 | · | 22.3 | |
| Quick Ratio | 6.5 | 10.2 | · | 9.1 | 10.0 | 6.7 | · | 2.5 | · | 4.8 | · | 6.0 | 8.6 | 9.2 | · | 21.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.57 | $5.25 | · | $6.79 | $0.81 | $0.96 | · | $1.49 | · | $2.79 | · | $4.07 | $4.86 | $5.56 | · | $6.93 | |
| Cash Flow / Share | · | $-1.10 | · | · | · | $-0.38 | · | · | · | $-0.67 | · | · | · | $-0.69 | · | · | |
| Cash / Share | $3.43 | $3.50 | · | $5.29 | $0.50 | $0.68 | · | $1.78 | · | $2.03 | · | $2.90 | $2.99 | $2.77 | · | $2.30 | |
| EPS (TTM) | $-26.82 | $-27.80 | · | $-22.14 | $-27.92 | $-26.84 | · | $-9.56 | $-3.04 | $-3.05 | · | $-3.17 | $-2.83 | $-2.70 | · | $-2.18 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-141M | $-129M | · | $-38M | $-60M | $-80M | · | $-109M | $-116M | $-116M | · | $-121M | $-108M | $-102M | · | $-82M | |
| Market Cap | $87M | $97M | · | $16M | $119M | $111M | · | $172M | · | $1.05B | · | · | · | · | · | · | |
| P/E | -0.3 | -0.4 | · | -0.2 | -0.1 | -0.1 | · | -0.5 | -8.7 | -9.0 | · | · | · | · | · | · | |
| P/B | 2.6 | 2.0 | · | 0.6 | 3.7 | 3.0 | · | 3.0 | · | 9.8 | · | · | · | · | · | · | |
| P / Tangible Book | 2.6 | 2.0 | · | 0.6 | 3.7 | 3.0 | · | 3.0 | 12.2 | 9.8 | · | · | · | · | · | · | |
| P / Cash Flow | · | -4.6 | · | · | · | -7.6 | · | · | · | -40.7 | · | · | · | · | · | · | |
| Earnings Yield | -291.8% | -270.4% | · | -534.8% | -924.5% | -941.8% | · | -214.3% | -11.5% | -11.1% | · | · | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-106M | $-97M | $-118M | $-96M | $-55M |
| Verwässerte EPS | $-24.70 | $-25.19 | $-3.09 | $-2.53 | $-1.49 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.9 | 4.2 | 5.4 | 9.7 | 28.1 |
| Quick Ratio | 1.9 | 3.9 | 5.1 | 9.3 | 27.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-97M | $-101M | $-74M | $-45M |
Institutionelle Eigentümer (13F) 46 Einreicher · $67.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
46
Gehaltener Wert
$67.9M
Neue Positionen
7
Geschlossene Positionen
3
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 7 (+1 vs. Vorquartal) | 3 (-3 vs. Vorquartal) | 8 (-3 vs. Vorquartal) | 7 (+1 vs. Vorquartal) | +817K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $17.087.169 | 1.859.322 | 25,17% | Aktien |
| ADAR1 Capital Management, LLC | $7.141.549 | 777.100 | 10,52% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $5.831.413 | 634.539 | 8,59% | Aktien |
| NEA Management Company, LLC | $4.267.818 | 464.398 | 6,29% | Aktien |
| Commodore Capital LP | $4.267.818 | 464.398 | 6,29% | Aktien |
| TCG Crossover Management, LLC | $4.267.818 | 464.398 | 6,29% | Aktien |
| Spruce Street Capital LP | $3.618.112 | 393.701 | 5,33% | Aktien |
| Kalehua Capital Management LLC | $3.618.112 | 393.701 | 5,33% | Aktien |
| Blackstone Inc. | $2.983.423 | 324.638 | 4,39% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.757.000 | 300.000 | 4,06% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.529.391 | 275.233 | 3,73% | Aktien |
| Seven Fleet Capital Management LP | $1.416.666 | 154.153 | 2,09% | Aktien |
| Propel Bio Management, LLC | $1.371.874 | 149.279 | 2,02% | Aktien |
| Simplify Asset Management Inc. | $1.371.874 | 149.279 | 2,02% | Aktien |
| VANGUARD GROUP INC | $1.164.183 | 153.789 | 1,71% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $739.513 | 80.418 | 1,09% | Aktien |
| BlackRock, Inc. | $727.719 | 79.186 | 1,07% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $711.527 | 77.424 | 1,05% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $393.461 | 42.814 | 0,58% | Aktien |
| BANK OF AMERICA CORP /DE/ | $299.199 | 32.557 | 0,44% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $298.216 | 32.450 | 0,44% | Aktien |
| Laird Norton Wetherby Trust Company, LLC | $200.508 | 21.818 | 0,30% | Aktien |
| STATE STREET CORP | $150.137 | 16.337 | 0,22% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $135.351 | 14.728 | 0,20% | Aktien |
| NORTHERN TRUST CORP | $132.281 | 14.394 | 0,19% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $122.006 | 13.276 | 0,18% | Aktien |
| XTX Topco Ltd | $107.973 | 11.749 | 0,16% | Aktien |
| CITADEL ADVISORS LLC | $91.909 | 10.001 | 0,14% | Aktien |
| OSAIC HOLDINGS, INC. | $42.090 | 4.580 | 0,06% | Aktien |
| JPMORGAN CHASE & CO | $17.826 | 2.012 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $12.177 | 1.325 | 0,02% | Aktien |
| ROYAL BANK OF CANADA | $8.000 | 844 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $4.025 | 438 | 0,01% | Aktien |
| American Capital Advisory, LLC | $1.838 | 200 | 0,00% | Aktien |
| UBS Group AG | $1.802 | 196 | 0,00% | Aktien |
| ROTHSCHILD INVESTMENT LLC | $1.379 | 150 | 0,00% | Aktien |
| McIlrath & Eck, LLC | $843 | 82 | 0,00% | Aktien |
| MORGAN STANLEY | $818 | 89 | 0,00% | Aktien |
| US BANCORP \DE\ | $744 | 81 | 0,00% | Aktien |
| Global Retirement Partners, LLC | $477 | 52 | 0,00% | Aktien |
| BARCLAYS PLC | $386 | 42 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $310 | 33 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $184 | 20 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $110 | 12 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $94 | 10.230 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $55 | 6 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Portman David J., Sermonix Pharmaceuticals, Inc. | 31. August 2026 | 36,90% | Erste Einreichung | · | SEC |
| Joseph Edelman, Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund II, LP | 25. August 2026 | 19,99% | Änderung | · | SEC |
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund II, LP ×8 Einreichungen | 7. Mai 2026 | 19,99% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 21 Insider · 10 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark James Litton | PRESIDENT and CEO | 9. April 2026 A | 57.926 | 0 | 2 | $-45.480 |
| Leen Kawas | President & CEO | 18. Februar 2021 A | · | 0 | 0 | $0 |
| Robert Renninger | CHIEF FINANCIAL OFFICER | 9. April 2026 A | 15.851 | 0 | 2 | $-6.908 |
| Andrew Gengos | CFO and Chief Business Officer | 5. September 2024 S | 97.532 | 0 | 0 | $0 |
| Glenna Mileson | Chief Financial Officer | 19. Januar 2023 A | 159.930 | 0 | 0 | $0 |
| Rachel Lenington | COO and CDO | 5. September 2024 S | 20.870 | 0 | 0 | $0 |
| Mark Worthington | GENERAL COUNSEL and CCO | 9. April 2026 A | 18.376 | 0 | 2 | $-13.158 |
| Kevin Church | CHIEF SCIENTIFIC OFFICER | 9. April 2026 A | 25.178 | 0 | 2 | $-13.325 |
| Javier San Martin | CHIEF MEDICAL OFFICER | 9. April 2026 A | 15.887 | 0 | 2 | $-20.547 |
| Hans Moebius | Chief Medical Officer | 4. Januar 2024 A | 91.482 | 0 | 0 | $0 |
| Fred Callori | Direktor | 23. Juni 2026 A | · | 0 | 0 | $0 |
| Peter B. Silverman | Direktor | 23. Juni 2026 A | · | 0 | 0 | $0 |
| Barbara Kosacz | Direktor | 23. Juni 2026 A | · | 0 | 0 | $0 |
| Kelly A Romano | Direktor | 23. Juni 2026 A | 80.715 | 0 | 0 | $0 |
| Michael A. Panzara | Direktor | 23. Juni 2026 A | · | 0 | 0 | $0 |
| Natalie C. Holles | Direktor | 23. Juni 2026 A | · | 0 | 0 | $0 |
| Grant Pickering | Direktor | 23. Juni 2026 A | 25.783 | 0 | 0 | $0 |
| James A Johnson | Direktor | 23. Juni 2026 A | 5.000 | 0 | 0 | $0 |
| Joseph Edelman | Direktor | 23. Juni 2026 A | 3.114.805 | 0 | 0 | $0 |
| John M Fluke JR | Direktor | 9. April 2026 A | 144.884 | 0 | 0 | $0 |
| Tadataka Yamada | Direktor | 28. Mai 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 7 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 23.485 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 2.614 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 136 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 330 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 82.390 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 183.259 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 1.048 NS | 31. Juli 2026 | N-PORT |
LONA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$17.00
+252,7%
2 20,0%
Starker Kauf
7 70,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-09-29Mittelwert-Ziel $17.33 +259,6%
← Unter allen Zielen
Aktueller Preis $4.82
Tief$15.00
Mittelwert$17.33
Hoch$20.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LONA | $71M | -0.3 | · | · | -353.4% | · |
| GRCE | · | -9.9 | · | · | -12.3% | · |
| BTMD | · | 3.5 | -2.5% | 14.1% | -32.9% | · |
| VERU | $56M | -5.4 | 3.6% | · | -115.4% | · |
| GRCE | · | -9.9 | · | · | -12.3% | · |
| SCLX | · | · | · | · | · | · |
| MIRA | $63M | -1.1 | -40.3% | -10557.5% | -190.5% | · |
| CNTX | $135M | -3.9 | 112.7% | · | -50.5% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 14, 2026